SEC Comment Letter for PURPLE BIOTECH LTD. (PPBT) (CIK 0001614744) (PPBT) — Dec 13, 2016
PURPLE BIOTECH LTD. (PPBT) (CIK 0001614744)
Date: Dec. 13, 2016 · CIK: 0001614744 · Accession: 0000000000-16-104641
AI Filing Summary & Sentiment
Reasoning
Letter
December 13, 2016 Isaac Israel Chief Executive Officer Kitov Pharmaceuticals Holdings Ltd. One Azrieli Center, Round Tower, 23rd Floor 132 Menachem Begin Road, Tel Aviv 6701101, Israel Kitov Pharmaceuticals Holdings Ltd. Registration Statement on Form F-3 Filed December 12, 2016 File No. 333-215037Re: Dear Mr. Israel: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Josh Samples at (202) 551-3199 with any questions. Division of Corporation Finance Healthcare and Insurance
Show Raw Text
December 13, 2016
Isaac Israel
Chief Executive Officer
Kitov Pharmaceuticals Holdings Ltd.
One Azrieli Center, Round Tower, 23rd Floor
132 Menachem Begin Road, Tel Aviv 6701101, Israel
Kitov Pharmaceuticals Holdings Ltd.
Registration Statement on Form F-3
Filed December 12, 2016
File No. 333-215037Re:
Dear Mr. Israel:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Josh Samples at (202) 551-3199 with any questions.
Division of Corporation Finance
Healthcare and Insurance